Coffee Consumption Correlates With Better Cognitive Performance in Patients With a High Incidence for Stroke

Massimo Barbagallo1,2, Anne Springer3,4, Chiara Vanetta5

  • 1Department of Internal Medicine Cantonal Hospital of Baden Baden Switzerland.

Insights

Regular coffee consumption may benefit cognitive function in elderly individuals with atrial fibrillation. Higher intake correlated with better cognitive scores and reduced inflammation markers, suggesting a protective effect.

Area of Science:

  • Cardiology
  • Neurology
  • Nutritional Science

Background:

  • Atrial fibrillation is a known risk factor for cognitive impairment.
  • Coffee consumption offers cognitive benefits in healthy individuals, but its effect in patients with atrial fibrillation is debated.
  • This study investigated the impact of regular coffee consumption on cognitive decline in elderly patients diagnosed with atrial fibrillation.

Purpose of the Study:

  • To examine the association between regular coffee consumption and cognitive performance in elderly individuals with atrial fibrillation.
  • To explore the relationship between coffee intake and inflammatory markers in this patient group.
  • To determine if coffee consumption can mitigate cognitive decline in a vulnerable population.

Main Methods:

  • Cognitive function was assessed using a comprehensive neurocognitive test battery, including the Montreal Cognitive Assessment, Trail-Making Test, semantic fluency, and Digit-Symbol-Substitution Test.
  • Daily coffee consumption was quantified via a structured nutrition questionnaire.
  • Inflammatory markers, high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6), were measured. Linear mixed-effects models were employed for data analysis, controlling for potential confounders.

Main Results:

  • Higher coffee consumption (more than 5 cups/day) was associated with a significantly improved cognitive construct score compared to lower intake (<1 cup/day) (p=0.048).
  • While the Montreal Cognitive Assessment scores showed a positive trend with increased coffee intake, the difference was not statistically significant (p=0.163).
  • Inflammatory markers, particularly IL-6, showed a significant decrease with higher coffee consumption (p=0.017), while hs-CRP showed a non-significant trend towards reduction.

Conclusions:

  • Coffee consumption in patients with atrial fibrillation may be linked to enhanced cognitive performance.
  • Higher coffee intake appears to be associated with reduced systemic inflammation in this population.
  • Further research is warranted to validate these findings and explore the potential role of coffee in dietary recommendations for atrial fibrillation management.
Abstract